News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Psychedelics
Deals
Psychedelics, Solid Tumors Will Be Key Focuses for Investors in 2024
After oncology and neuroscience headlined biopharma investment in 2023, experts anticipate increased interest in the autoimmune and obesity spaces this year.
March 5, 2024
·
5 min read
·
Heather McKenzie
PRESS RELEASES
Press Releases
Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio
February 21, 2025
·
4 min read
Press Releases
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
November 19, 2024
·
4 min read
Press Releases
Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
September 10, 2024
·
4 min read
Press Releases
Quantum Research Group Survey Reports Investor Insights About Psychedelic Stocks
August 5, 2024
·
3 min read
Business
PurMinds Chief Scientific Officer to Speak at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
May 21, 2024
·
4 min read